IE 11 is not supported. For an optimal experience visit our site on another browser.

Berkeley Lovelace Jr.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.

Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.

Latest from Berkeley Lovelace Jr.

New Covid boosters work better against infection than previous shots, CDC finds

Omicron Covid booster vaccines are better at preventing Covid symptoms than the earlier doses, the CDC reported Tuesday.
11d ago

FDA approves 1st drug to delay the onset of Type 1 diabetes

The drug, called Tzield, is the first-ever FDA approved treatment intended to delay the onset of type 1 diabetes in adults and children ages 8 and up.
13d ago

FDA opens door to make opioid overdose antidote available over the counter

The Food and Drug Administration is pushing for drugmakers to apply for over-the-counter approval for naloxone, the opioid overdose antidote.
15d ago

FDA warns of rise in reports of child poisonings linked to cough medicine

Poison control centers in the U.S. have seen an increase in reports of kids taking benzonatate, a cough medicine, either accidentally or intentionally.
15d ago

Moderna says its updated booster raises antibodies against omicron subvariants

Moderna says its bivalent booster increases antibodies against omicron subvariants BA.4 and BA.5, as well as newer subvariant BQ.1.1.
17d ago

Myocarditis after Covid vaccination: Research on possible long-term risks underway

Myocarditis after receiving a Covid vaccine is rare. Pfizer and Moderna are researching possible long-term risks for those who recovered from heart problems after vaccination.
19d ago

California expected to partner with nonprofit Civica Rx to produce its own low-cost insulin, sources say

How much does insulin cost? California plans to partner for low-cost insulin with nonprofit Civica Rx to produce its own insulin.
20d ago

'So much relief': South Dakota voters pass Medicaid expansion

South Dakotans voted to pass a measure to expand Medicaid under the Affordable Care Act on Tuesday, providing tens of thousands of impoverished people with access to health care and dismissing state GOP attempts to sink the effort.
21d ago

Omicron symptoms: What we know about the illness caused by the new subvariants

What are omicron symptoms: Omicron subvariants may have different symptoms than previous Covid strains. What to look out for.
25d ago

Pfizer says omicron booster generates stronger immune response than original vaccine

Pfizer's omicron Covid booster generates stronger immune response against the omicron subvariants BA.4 and BA.5 compared to the original Covid, the company said Friday.
28d ago

Experimental RSV vaccine for pregnant women protects infants against severe illness, Pfizer says

Is there a vaccine for RSV? An experimental RSV vaccine for pregnant women from Pfizer is effective at protecting their babies against severe illness.